General Affairs Committee
March 3, 2025
Committee Chair: Sen. Holdcroft | Bills Heard: 4 | Full Transcript (PDF)
LB651: Medical Cannabis Patient Protection Act
Introduced by: Sen. Conrad | Testimony: 107 proponents, 9 opponents, 2 neutral | Read bill text (PDF)
Sen. Conrad's LB651 would establish medical cannabis access framework backed by overwhelming voter support, but faces federal preemption and litigation concerns.
Why it matters: With 70% of Nebraskans voting for medical cannabis in November, the question is how—not whether—to implement it. Patients with epilepsy, cancer, and chronic pain are waiting for legal access. But the Attorney General's pending litigation and federal Schedule I classification create legal uncertainty.
What they're saying: - Proponents: "The people have spoken resoundingly. We need to respect their will and provide safe, regulated access. Other states have done this successfully." (Sen. Conrad) Multistate operators emphasized that strict licensing and testing prevent the black market problems seen in poorly-regulated states like Oklahoma. - Opponents: "The Legislature has no duty to act. The initiatives are self-executing. If we pass laws now and the Supreme Court invalidates the petitions, our work is wasted." (Attorney General's Office) DHHS warned that cannabis lacks FDA approval and poses mental health risks, especially for youth.
By the numbers: 107 proponents, 9 opponents, 2 neutral. Every legislative district passed the measure with an average of 71.3% support. Fiscal note projects $1.3-28 million in revenue depending on licensing assumptions.
What's next: No vote taken. Committee will likely consider amendments addressing delivery methods, practitioner qualifications, and tax rates before advancing to General File. Requires 33 votes (supermajority) to modify voter-approved initiative.
Committee sentiment: Supportive: Sen. Cavanaugh, Sen. Rountree Skeptical: Sen. Andersen, Sen. Storm Unclear: Sen. DeKay
Sentiment estimated from questions and comments — not stated positions.
LB677: Nebraska Medical Cannabis Registry Act
Introduced by: Sen. Hansen | Testimony: 108 proponents, 5 opponents, 2 neutral | Read bill text (PDF)
Sen. Hansen's LB677 would create tightly regulated medical cannabis program with limited licensing and strict tracking, but faces criticism over last-minute 116-page amendment and federal preemption concerns.
Why it matters: With 72% average district support for medical cannabis, the Legislature faces pressure to implement voter will responsibly. Hansen's bill attempts to prevent the black market problems seen in loosely regulated states while protecting youth and public health. But the massive amendment filed Friday—after proponents had already testified—raises questions about transparency and adequate review.
What they're saying: - Proponents: "Limited licensing prevents oversaturation and keeps focus on medical needs. Seed-to-sale tracking and mandatory testing ensure safety." (Hansen) Multistate operators praised the framework, with one noting Missouri's model generated $8 million for veterans in year one. - Opponents: "The 116-page amendment dropped the day before hearing is bad policymaking. Federal law makes this illegal regardless. The Attorney General will sue if you license dispensaries." (Attorney General's Office)
By the numbers: 108 proponents, 5 opponents, 2 neutral. Fiscal note projects $1.3 million revenue but $5.6 million expenditure (likely overstated due to assumptions about separate agency). 85 certified DREs available for impaired driving enforcement.
What's next: No vote taken. Committee will likely request revised fiscal note after amendments finalized. Requires 33 votes to advance. Sponsors indicated willingness to work with committee on refinements.
Committee sentiment: Supportive: Sen. Hansen, Sen. Cavanaugh, Sen. Rountree Skeptical: Sen. Storm, Sen. Andersen
Sentiment estimated from questions and comments — not stated positions.
LB483: Medical Cannabis Restrictions Bill
Introduced by: Sen. Storm | Testimony: 13 proponents, 161 opponents, 1 neutral | Read bill text (PDF)
Sen. Storm's LB483 would sharply restrict medical cannabis to pills and tinctures only, but faces overwhelming opposition from patients and advocates who say it guts voter-approved initiative.
Why it matters: Storm's bill represents the most restrictive approach, citing legitimate health concerns about smoking/vaping carcinogens and secondhand smoke. But it explicitly repeals key voter-approved language—requiring a 33-vote supermajority—and patients argue it would deny them necessary treatment options. The 13-161 vote count shows deep committee skepticism.
What they're saying: - Proponents: "Smoking cannabis contains the same toxins as tobacco. No prescribed medications are smoked. We should treat this as medicine, not a vice." (DHHS) Storm emphasized secondhand smoke risks and the need to prevent a gateway to recreational marijuana. - Opponents: "This is a poison pill. 637,126 Nebraskans voted for 5 ounces and all delivery methods. You're telling epilepsy patients to wait 45 minutes for a pill to work during a seizure?" (Patient advocates) Industry testified that pills/tinctures represent only 5% of market; restricting to these would make business unviable.
By the numbers: 13 proponents, 161 opponents, 1 neutral. 300 mg limit is 1/100 of the 5 ounces voters approved. Some patients take 1,100+ mg daily of other medications.
What's next: No vote taken. Storm indicated openness to amendments including nebulizers and suppositories. Requires 33 votes to advance due to modifying voter initiative. Likely to be significantly amended or not advanced.
Committee sentiment: Supportive: Sen. Storm, Sen. Andersen Opposed: Sen. Cavanaugh Unclear: Sen. DeKay, Sen. Rountree
Sentiment estimated from questions and comments — not stated positions.
LB705: Nebraska Medical Cannabis Justice Act and Cannabis Conviction Clean Slate Act
Introduced by: Sen. McKinney | Testimony: 12 proponents, 9 opponents, 1 neutral | Read bill text (PDF)
Sen. McKinney's LB705 would add social equity and criminal record expungement provisions to medical cannabis program, addressing war on drugs' disproportionate impact on communities of color.
Why it matters: While other bills focus on patient access and regulation, McKinney's bill highlights a critical gap: the war on drugs devastated Black and brown communities through disparate enforcement, even though usage rates were similar across racial groups. Social equity programs in other states have created pathways for historically marginalized entrepreneurs. But the bill faces the same federal preemption and litigation concerns as other measures.
What they're saying: - Proponents: "The war on drugs was steeped in racism and money. If we're going to legalize cannabis, we must address the communities it harmed and give them a chance to participate in the legal industry." (McKinney) Hawkins praised the bill for centering equity, noting previous bills were written by lobbyists for 'good old white boy networks.' - Opponents: "Federal law makes this illegal. Pending litigation creates uncertainty. The bill allows practitioners to recommend more than 5 ounces voters approved." (Attorney General's Office)
By the numbers: 12 proponents, 9 opponents, 1 neutral. Bill is 111 pages—longest of the four medical cannabis bills heard.
What's next: No vote taken. McKinney indicated willingness to amend terminology (replacing 'marijuana' with 'cannabis'). Requires 33 votes to advance. Committee may consider incorporating social equity and clean slate provisions into other bills rather than advancing LB705 separately.
Committee sentiment: Supportive: Sen. McKinney, Sen. Rountree Unclear: Sen. Andersen
Sentiment estimated from questions and comments — not stated positions.
Session Notes
Joint hearing held for LB651 and LB677 on March 3, 2025. Committee heard testimony on four medical cannabis bills total: LB651 (Sen. Conrad), LB677 (Sen. Hansen), LB483 (Sen. Storm), and LB705 (Sen. McKinney). Hearing lasted approximately 8+ hours with 100+ testifiers. Key procedural notes: (1) Testifiers required to specify which bills they were testifying on using green sheets; (2) Three-minute light system used for all testifiers; (3) Written position comments had to be submitted by 8 a.m. day of hearing via Legislature website; (4) ADA testimony submissions accepted in writing for those unable to testify in person; (5) Committee clerk Barb Dorn and research analyst Micah Chaffee assisted. Pages: Tate Smith (UNL junior, political science) and Arvna Rishi (UNL junior, political science). No votes were taken on any bills during the hearing. All bills require 33-vote supermajority to advance due to modifying voter-approved initiatives.
Generated by NE Wire Service | Source: Nebraska Legislature Transcribers Office This is an AI-generated summary. Verify all claims against the official transcript.